Transformative adaptation is gaining recognition as the appropriate response to climate change as the current adaptive measures reach their limits. In addressing health risks associated with heat waves, air pollution, wildfire emission and pollen, the implementation of comprehensive transformative adaptation remains largely unreported in Europe. healthRiskADAPT’s objective is to develop and implement a health risk assessment system for Mediterranean, Alpine and Continental regions. Its contents and tools will be in line with Climate-ADAPT described Urban adaptation support tool. This will support empowerment of local and regional authorities to make informed decisions in strategic planning, management and daily operational mitigation of health challenges related to climate change. healthRiskADAPT will address the fundamental causes of vulnerability and implement concrete adaptation measures aiming to mitigate the health impacts of climate change. The key details of this approach include: 1) Co-creation with users of integrated transformative adaptation options encompassing technical, nature based, and social solutions, reducing the impact of climate-related risks on human health in both indoor and outdoor environments. 2) Vulnerability assessments, health indicators, and risk indices related to climate change impact on health, considering different temporal and spatial scales. 3) Interactive and user-friendly toolkit for local & regional authorities to assess hazards, vulnerability, and risks specific to their regions. These toolkits will facilitate the prioritization, planning, and evaluation of adaptation options. healthRiskADAPT will use various communication techniques to actively engage with all stakeholders involved in the adaptation process, and develop an upscaling strategy to meet the ambitions of the Climate mission. Furthermore, we seek to enhance the preparedness of the healthcare system to respond effectively to the challenges posed by the effects of climate change.

With an increasingly growing population in Europe, cognitive impairments as well as heart diseases are a major social and health issue. 1.2 million people in Europe are affected by Parkinson's disease (PD) while Alzheimer’s disease remains one of the biggest global public health challenges our generation is facing, while Cardiovascular disease represented the 31% of all global deaths in 2016. Based on these facts, the affecTive basEd iNtegrateD carE for betteR Quality of Life TeNDER project will create an integrated care ecosystem for assisting people with chronic diseases of Alzheimer’s (AD), Parkinson’s (PD) and comorbidity with Cardiovascular Diseases (CVD) through the use of affect based micro tools. These microservices will recognise the mood of a person and thus adapt the system’s probes to the person’s needs via a multi-sensorial system, even in the most severe cases, and match with clinical (from Electronic Health Records EHRs) and clerical patient information, while preserving privacy, monitoring the ethical principles, providing data protection and security, with the result of an increased Quality of Life (QoL). In addition, interactive communication and social services will strength the elderly support, extending their autonomy and care supply chain. TeNDER will perform 5 large scale pilots, involving 5 user partners and 1500+ TeNDER final users in 4 different European regions, with at least 735 patients (+40% in the patients control group, making a total of 1030 patients), 85 health professionals (physicians mainly), 30 social workers, 570 caregivers (professional and relatives) and 60 other staff (clerks, Hospital IT support, etc.), to provide tailor suited integrated care services to promote wellbeing and health recovery. TeNDER will provide 4 different scenarios according to the patients pathways (home, daycare centre, rehabilitation centre/rooms, and hospital).

Medication errors occur daily and form a major burden to society. Medication errors often lead to adverse drug reactions, lengthened hospital stays, increased healthcare costs, and in the most severe cases, increased mortality. Medication errors pose a significant risk to the European population. It is estimated that 4,7 million Europeans are harmed by a medication error every year, which amounts to preventable healthcare costs in excess of €11 billion a year. Strikingly, around 50% of medication errors can be stopped at the patient’s bedside. MedEye is an innovative medication verification suite that scans, detects and verifies medication at the bedside. MedEye stops medication errors from taking place by verifying medication before it is administered to patients. MedEye has already been tested and validated in three Dutch hospitals with excellent results. In this project, activities will be performed to push MedEye onto the European market and facilitate its deployment on a large scale. MedEye will be integrated with IT systems that serve a major part of European medical centers. Developments will also be performed to enable the sale, deployment and support of MedEye through distributors. Two launching pilots will be performed to establish transnational proof of performance and cost-effectiveness, which will be instrumental in penetrating the European markets. Given the diversity of the European healthcare landscape, a thorough market research will be performed to gear the commercialization strategy towards individual countries. Together, the activities in this project will provide access to the main EU market and facilitate a wide deployment of MedEye throughout Europe.

EURO-CAS, European eHealth Interoperability Conformity Assessment Scheme aims at maintaining and developing the adoption and take-up of testing the interoperability of ICT solutions against identified eHealth standards and profiles defined in the eHealth European Interoperability Framework (eEIF). The key deliverable is a sustainable Conformity Assessment Scheme (CAS) for Europe. Based on recommendations of the Antilope project and the state-of-art in interoperability testing in eHealth, EURO-CAS is committed to putting in place an operational CAS based on ISO/IEC 17025 that will meet the interoperability requirements of European eHealth projects as well as national and regional eHealth programs. This will allow testing the interoperability capabilities of products and services for a single digital market in eHealth in Europe in line with the Digital Agenda for Europe and based on international profiles and standards. The project will gather a multi-disciplinary consortium of high-level expertise, including organizations focused on implementing international standards as well as industry stakeholders and healthcare providers that will 1) review the state of the art of existing interoperability CAS, 2) collect the requirements and needs from cross border, national/regional levels, 3) establish the CAS for Europe with implementation guidelines and governance, 4) propose business models for the CAS for Europe, 5) validate results and foresee national/regional adoption, 6) inform and educate eHealth stakeholders and motivate industry and projects to participate in a European accreditation process. The CAS for Europe will provide a comprehensive framework completing the eEIF and aligned with the international CAS. Its flexibility will allow better sustainability and harmonization at European, national and regional levels.